Table 1 Correlations of V-Glut5 expression with clinicopathological features of colorectal cancer in all cases
Variables | n | V-Glut5 | χ2 | p | |
|---|---|---|---|---|---|
Negative | Positive | ||||
Age(years) | |||||
 60 | 233 | 165 (36.8%) | 68 (15.2%) | 4.534 | 0.038* |
 ≥ 60 | 215 | 170 (37.9%) | 45 (10.0%) | ||
Gender | |||||
 Male | 263 | 199 (44.4%) | 64 (14.3%) | 0.15 | 0.740 |
 Female | 185 | 137 (30.6%) | 48 (10.7%) | ||
Tumor location | |||||
 Colon cancer | 224 | 175 (39.1%) | 49 (10.9%) | 2.333 | 0.156 |
 Rectal cancer | 224 | 160 (35.7%) | 64 (14.3%) | ||
Differentiation | |||||
 well-moderate | 336 | 249 (55.6%) | 87 (19.4%) | 0.571 | 0.529 |
 poor | 112 | 87 (19.4%) | 25 (5.6%) | ||
Tumor diameter | |||||
 < 5 cm | 224 | 167 (37.3%) | 57 (12.7%) | 0.048 | 0.913 |
  ≥ 5 cm | 224 | 169 (37.7%) | 55 (12.3%) | ||
T-stage | |||||
 T1-T2 | 112 | 82 (18.3%) | 30 (6.7%) | 0.254 | 0.616 |
 T3-T4 | 336 | 253 (56.5%) | 83 (18.5%) | ||
N-Lymphatic metastasis | |||||
 No | 296 | 225 (49.8%) | 71 (16.3%) | 0.478 | 0.492 |
 Yes | 152 | 113 (25.2%) | 39 (8.7%) | ||
M | |||||
 M0 | 440 | 330 (73.7%) | 110 (24.6%) | 0 | 1 |
 M1 | 8 | 6 (1.3%) | 2 (0.4%) | ||
Clinical stage | |||||
 I-II | 292 | 219 (48.9%) | 73 (16.3%) | 0.210 | 0.649 |
 III-IV | 156 | 117 (26.1%) | 39 (8.7%) | ||